Brianna K Smith1, Ross H Roberts2,3, Frank A Frizelle2,3. 1. Christchurch Public Hospital, Canterbury District Health Board, 2 Riccarton Ave, Christchurch Central, Christchurch, 8011, New Zealand. brianna.kate2@gmail.com. 2. Department of General Surgery at Christchurch Public Hospital, Canterbury District Health Board, Christchurch, New Zealand. 3. University of Otago Christchurch, Christchurch, New Zealand.
Abstract
OBJECTIVE: To determine the effects of perioperative high (80%) versus low (30%) fraction of inspired oxygen (FiO2) on surgical site infection (SSI) and mortality in adult surgical patients. BACKGROUND: The routine use of high fraction perioperative oxygen in patients is "standard of care" and recommended by the World Health Organisation; however, whether there is truly any benefit to this therapy has been challenged by some authors. Questions have also been raised about the possibility of harm from oxygen therapy. METHOD: Randomised control trials comparing high-to-low FiO2 were located by searching MEDLINE, Embase, CENTRAL and Web of Science. The primary outcomes were SSI up to 15 days and up to any time point postoperatively and mortality up to 30 days. The data were analysed using random effects meta-analysis. RESULTS: Twelve studies involving 10,212 participants were included. At 15 days postoperatively, and at the longest point of post-operative follow-up, there was no statistically significant reduction in the risk of SSI when comparing patients who received a perioperative FiO2 of 30% to those with an FiO2 of 80% (RR 1.41, 95% CI 1.00-2.01, p 0.05 and RR 1.23, 95% CI 1.00-1.51, p 0.05). There was no statistically significant difference in mortality between the 30% FiO2 and the 80% FiO2 groups (RR 1.12, 95% CI 0.56-2.22, p 0.76). CONCLUSION: This meta-analysis showed no statistically significant difference in post-operative SSI or mortality when comparing patients receiving an FiO2 of 80% to those receiving an FiO2 of 30%.
OBJECTIVE: To determine the effects of perioperative high (80%) versus low (30%) fraction of inspired oxygen (FiO2) on surgical site infection (SSI) and mortality in adult surgical patients. BACKGROUND: The routine use of high fraction perioperative oxygen in patients is "standard of care" and recommended by the World Health Organisation; however, whether there is truly any benefit to this therapy has been challenged by some authors. Questions have also been raised about the possibility of harm from oxygen therapy. METHOD: Randomised control trials comparing high-to-low FiO2 were located by searching MEDLINE, Embase, CENTRAL and Web of Science. The primary outcomes were SSI up to 15 days and up to any time point postoperatively and mortality up to 30 days. The data were analysed using random effects meta-analysis. RESULTS: Twelve studies involving 10,212 participants were included. At 15 days postoperatively, and at the longest point of post-operative follow-up, there was no statistically significant reduction in the risk of SSI when comparing patients who received a perioperative FiO2 of 30% to those with an FiO2 of 80% (RR 1.41, 95% CI 1.00-2.01, p 0.05 and RR 1.23, 95% CI 1.00-1.51, p 0.05). There was no statistically significant difference in mortality between the 30% FiO2 and the 80% FiO2 groups (RR 1.12, 95% CI 0.56-2.22, p 0.76). CONCLUSION: This meta-analysis showed no statistically significant difference in post-operative SSI or mortality when comparing patients receiving an FiO2 of 80% to those receiving an FiO2 of 30%.
Authors: Christian S Meyhoff; Lars N Jorgensen; Jørn Wetterslev; Karl B Christensen; Lars S Rasmussen Journal: Anesth Analg Date: 2012-07-13 Impact factor: 5.108
Authors: A Kurz; T Kopyeva; I Suliman; A Podolyak; J You; B Lewis; C Vlah; R Khatib; A Keebler; R Reigert; M Seuffert; L Muzie; S Drahuschak; E Gorgun; L Stocchi; A Turan; D I Sessler Journal: Br J Anaesth Date: 2017-11-23 Impact factor: 9.166
Authors: Johanna Turtiainen; Eija I T Saimanen; Teemu J Partio; Kimmo T Mäkinen; Matti T Reinikainen; Jyrki J Virkkunen; Kari S Vuorio; Tapio Hakala Journal: World J Surg Date: 2011-06 Impact factor: 3.352
Authors: Christian S Meyhoff; Jørn Wetterslev; Lars N Jorgensen; Steen W Henneberg; Claus Høgdall; Lene Lundvall; Poul-Erik Svendsen; Hannah Mollerup; Troels H Lunn; Inger Simonsen; Kristian R Martinsen; Therese Pulawska; Lars Bundgaard; Lasse Bugge; Egon G Hansen; Claus Riber; Peter Gocht-Jensen; Line R Walker; Asger Bendtsen; Gun Johansson; Nina Skovgaard; Kim Heltø; Andrei Poukinski; André Korshin; Aqil Walli; Mustafa Bulut; Palle S Carlsson; Svein A Rodt; Liselotte B Lundbech; Henrik Rask; Niels Buch; Sharafaden K Perdawid; Joan Reza; Kirsten V Jensen; Charlotte G Carlsen; Frank S Jensen; Lars S Rasmussen Journal: JAMA Date: 2009-10-14 Impact factor: 56.272
Authors: Sarah Dehne; Verena Spang; Rosa Klotz; Laura Kummer; Samuel Kilian; Katrin Hoffmann; Martin A Schneider; Thilo Hackert; Markus W Büchler; Markus A Weigand; Jan Larmann Journal: Front Med (Lausanne) Date: 2021-11-26